Viewing Study NCT04796012


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT04796012
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-02-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
Sponsor: University of Texas Southwestern Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module